The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
A glycosyloxyflavone that is 3,5,7-trihydroxy-4'-methoxy-8-prenylflavone in which the hydroxy group at position 3 has been converted into its alpha-L-rhamnopyranoside.
baohuoside I results in decreased phosphorylation of AKT1 protein baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of AKT1S1 protein] baohuoside I results in decreased phosphorylation of AKT1S1 protein
baohuoside I results in decreased phosphorylation of BRAF protein baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of BRAF protein]
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of AKT1S1 protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of BRAF protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MTOR protein]
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] baohuoside I results in decreased phosphorylation of EGFR protein
baohuoside I binds to and results in increased degradation of ESR1 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [baohuoside I results in increased degradation of ESR1 protein]; ESR1 inhibits the reaction [baohuoside I results in decreased expression of and affects the localization of NR0B2 protein]
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] baohuoside I results in decreased phosphorylation of MAPK1 protein
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein] baohuoside I results in decreased phosphorylation of MAPK3 protein
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MTOR protein] baohuoside I results in decreased phosphorylation of MTOR protein
baohuoside I results in decreased expression of and results in decreased activity of and affects the localization of NR0B2 protein; ESR1 inhibits the reaction [baohuoside I results in decreased expression of and affects the localization of NR0B2 protein] baohuoside I results in decreased expression of NR0B2 mRNA; baohuoside I results in decreased expression of NR0B2 protein
baohuoside I results in increased cleavage of PARP1 protein Dinoprostone inhibits the reaction [baohuoside I results in increased cleavage of PARP1 protein]; PTGS2 mutant form promotes the reaction [baohuoside I results in increased cleavage of PARP1 protein]
baohuoside I results in decreased expression of PTGS2 [baohuoside I results in decreased expression of PTGS2] which results in decreased abundance of Dinoprostone; PTGS2 mutant form promotes the reaction [baohuoside I results in increased cleavage of PARP1 protein]
baohuoside I results in increased expression of SLC10A1 protein baohuoside I results in increased expression of SLC10A1 mRNA; baohuoside I results in increased expression of SLC10A1 protein